Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
EV/Core EBITDA

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.0815.149.6951.0913.84

What is the latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE ?

The latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE is 9.08 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20259.08
Mar202415.14
Mar20239.69
Mar202251.09
Mar202113.84

How is EV/Core EBITDA of STRIDES PHARMA SCIENCE Trending?

Years EV/Core EBITDA % Change
Mar2025 9.08
-40.03
Mar2024 15.14
56.24
Mar2023 9.69
-81.03
Mar2022 51.09
269.15
Mar2021 13.84 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare EV/Core EBITDA ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹10,092.7 Cr -8% 3.9% 57.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,909.0 Cr -2.5% 1% 7.5% Stock Analytics
DIVIS LABORATORIES ₹173,930.0 Cr -3.1% 0.3% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,181.0 Cr -4.9% 2.8% 37.8% Stock Analytics
CIPLA ₹112,353.0 Cr -1.6% 5.6% -5.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,608.0 Cr -3.2% -3.1% 4.8% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-8%

3.9%

57.1%

SENSEX

-1.5%

-3.4%

-9.1%


You may also like the below Video Courses